Juno Therapeutics Inc Stock

Stocks

18-03-29	Takeda Pharmaceutical : Merits of any Takeda bid for Shire questioned, shares slide	RE
18-03-29	Takeda Pharmaceutical : Merits of any Takeda bid for Shire questioned, shares slide	RE
18-03-28	Takeda Pharmaceutical : Drugmaker Shire soars as Japan's Takeda considers bid	RE
18-02-22	Gilead Sciences : Sangamo in $3 billion gene-editing deal with Gilead	RE
18-01-29	Ablynx : Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom	RE
18-01-22	Stocks hit record as senators reach deal to end shutdown	RE
18-01-22	Ablynx : Biotech M&A takes off as Sanofi and Celgene spend $20 billion	RE
18-01-22	Biogen : Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion	RE
17-07-12	Novartis : FDA panel backs Novartis' pioneering new cancer gene therapy	RE
17-03-01	Juno Therapeutics : Yahoo says about 32 million accounts accessed using 'forged cookies'	RE
17-03-01	Juno Therapeutics : Yahoo says about 32 million accounts accessed using 'forged cookies'	RE
16-07-12	Juno Therapeutics : Shares of Juno Therapeutics jump after FDA removes clinical hold on cancer drug trial	RE
15-07-15	Celgene : Wall Street lauds Celgene's $7.2 billion Receptos buy	RE

18-02-21	Juno Therapeutics : Celgene Receives Antitrust Clearance for Juno Acquisition	BU
18-01-25	The Law Offices of Vincent Wong : Reminds Investors of an Investigation of Juno Therapeutics, Inc. in Connection with the Sale of the Company to Celgene Corp.	BU
18-01-24	The Law Offices of Vincent Wong : Notifies Investors of an Investigation of Juno Therapeutics, Inc. in Connection with the Sale of the Company to Celgene Corp.	BU
18-01-24	WeissLaw LLP : Investigates Juno Therapeutics Inc. Acquisition	PR
18-01-23	Rigrodsky & Long, P.A. Announces Investigation of Juno Therapeutics, Inc. Buyout	BU

18-01-29	Ablynx : Sanofi s'offre une nouvelle biotech en achetant Ablynx 3,9 milliards d'euros
18-01-29	Sanofi s'offre une nouvelle biotech en achetant Ablynx E3,9 mds
18-01-22	Apple : Wall Street finit en hausse, accord sur le "shutdown"
18-01-22	BOURSE : Wall Street finit à des records après l'accord au Sénat mettant fin au "shutdown"
18-01-22	Barclays : Les Bourses européennes clôturent en hausse, le M&A éclipse le "shutdown"

Manager	Title	Age	Since
Katherine Reynolds Kelly SEC	Corporate Secretary	50	-
Jonathan Biller TRE	Treasurer	63	-

Director	Title	Age	Since
Sophia Park BRD	Director/Board Member	-	-
Sandra Ramos-Alves BRD	Director/Board Member	-	-
Elisabeth Bradley BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JUNO THERAPEUTICS INC	-.--%	+0.42%	-	-	0
WUXI APPTEC CO., LTD.	+1.10%	+1.03%	+62.53%	+70.47%	67.53B
ARGENX SE	+1.35%	+8.80%	+14.06%	+92.87%	60.74B
LONZA GROUP AG	+0.38%	-0.89%	+20.16%	+98.57%	55.66B
BEONE MEDICINES AG	+0.20%	+8.72%	+11.53%	+111.72%	47.97B
IQVIA HOLDINGS INC.	-1.84%	+1.85%	+22.14%	+39.30%	45.24B
REVOLUTION MEDICINES, INC.	-1.49%	+0.19%	+170.38%	+805.80%	39.08B
CELLTRION, INC.	+1.21%	+4.75%	+27.30%	+52.81%	35.34B
GENMAB A/S	-0.87%	-2.61%	+80.11%	+56.78%	33.45B
INSMED INCORPORATED	-0.99%	+9.24%	-38.88%	+397.11%	26.49B
Average	-0.10%	+2.70%	+41.04%	+191.72%	46B
Weighted average by Cap.	+0.08%	+2.88%	+41.38%	+167.19%

Employees

Sector